Nohla Therapeutics

Biotechnology ResearchWashington, United States0-1 Employees

Nohla Therapeutics is a cellular therapy company driven to provide leading off the shelf therapies for patients with critical diseases.  Nohla’s first product is a universal donor cell therapy targeting hematopoietic recovery and chemotherapy induced neutropenia, and is being extended to treat a range of other medical indications.  This and other products in the pipeline are based on a unique umbilical cord blood expansion platform developed at the Fred Hutchinson Cancer Research Center

Sign up for free to view info

Email Format Employee directory